SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: stock bull who wrote (2438)5/5/1998 4:47:00 PM
From: art slott  Read Replies (1) | Respond to of 3725
 
The Pet Scan is the best at looking at changes in the brain that occur from drugs or external stimuli. This has become a "hot"area. The costs of the scans in an era of tight hospital budgets has been the achillies heel.
Durro, whats your expert opinion?

Art



To: stock bull who wrote (2438)5/5/1998 6:08:00 PM
From: Bruce Rozenblit  Read Replies (1) | Respond to of 3725
 
I don't know what to make of this. I usually have ton of stuff to say but I need to do some research. Looks like Positron was in deep doo-doo and needed working capitol fast. I hope Imat was able to exact a bargain price for this new venture. Somehow I fear that this will be another drain on the balance sheet. If Positron was profitable, they wouldn't have been in such deep trouble.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News